Currently, Entest is focused in one area that shows promise for development of an underserved market niche with potentially high demand.
Entest has developed ImenVax™, a novel immuno-therapeutic
cancer vaccine which is used in conjunction with an encapsulation devise that enables the patient's body to fight and kill cancer cells.
Entest BioMedical, Inc. | 4700 Spring Street, Suite 304 | La Mesa, CA 91942 | Phone: (619) 644-3344 | Fax: (619) 330-2328
